Latest Unitaid Stories
New funding supports the STAND trial and advances other new tools critical for tackling TB in the Asia-Pacific region and around the world NEW YORK, March 24, 2015 /PRNewswire-USNewswire/
Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- TB Alliance has announced
GENEVA, February 24, 2015 /PRNewswire/ -- Company joins five other MPP patent holders in efforts to improve HIV paediatric
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years NEW YORK, Feb.
NEW YORK, Jan.
GENEVA, December 1, 2014 /PRNewswire/ -- Licence will support the work of the recently launched Paediatric HIV Treatment Initiative (PHTI) to Develop Better Adapted
Brock Will Lead Resource Development, Advocacy, Community Engagement Efforts in Support of Promising Research Pipeline NEW YORK, July 31, 2014 /PRNewswire-USNewswire/
Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the
CAMBRIDGE, Mass., June 3, 2014 /PRNewswire/ -- The National Institute of Health has awarded a Phase I Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for a point-of-care
Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates NEW YORK, May 14, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization
- Large; stout; burly.